Polycythemia vera is a myeloproliferative neoplasm characterized by erythrocytosis driven by constitutive activation of the erythropoietin (Epo) receptor by mutant JAK2 protein kinase. The gene discussed is JAK2; the disease is myeloproliferative disorder.